The NIH Found
the Link. The Companies
Knew the Risk.
A landmark 2022 NIH study found that women who used chemical hair relaxers more than four times a year had more than twice the risk of developing uterine cancer. L'Oréal, Revlon, and other major manufacturers face active lawsuits. Attorneys handling hair relaxer settlements are reviewing claims from women diagnosed with uterine cancer, ovarian cancer, and other serious conditions — nationwide, at no cost.
Litigation Status
Federal MDL Active.
Major Brands Named.
The hair relaxer MDL in the Northern District of Illinois is consolidating thousands of claims from across the country. Major manufacturers are defendants. New cases are still being accepted.
The hair relaxer MDL in the Northern District of Illinois consolidates claims against L'Oréal, Revlon, Dabur/Namaste (ORS), Strength of Nature, and other manufacturers. Thousands of women have filed claims and new cases continue to be accepted.
The 2022 NIH/NIEHS study found women who used hair relaxers more than four times per year had more than double the risk of uterine cancer. The study followed over 33,000 women across the United States — it is the scientific foundation of current litigation.
Attorneys in this network handle hair relaxer lawsuits on pure contingency. No retainer, no upfront fees. If no settlement or verdict is recovered on your behalf, you owe nothing at any stage of the process.
"The NIH published the research. The companies had years to warn women. They didn't."
Products & Legal Theories
Which Brands.
Which Injuries.
Why They're Liable.
Hair relaxer lawsuits rest on documented chemical hazards — endocrine disruptors, formaldehyde releasers, and carcinogens — that manufacturers formulated into products marketed primarily to Black women for decades. A connected attorney will assess which claims apply to your situation.
Uterine Cancer — The Core Hair Relaxer Claim
The NIH's 2022 study established the clearest scientific link between hair relaxer use and uterine cancer — the most rapidly increasing cancer among women in the United States. Uterine cancer claims following regular, long-term hair relaxer use are the primary category of claims in the active MDL.
L'Oréal, Soft Sheen & Dark & Lovely — Failure to Warn
L'Oréal, through its Soft Sheen Products subsidiary, manufactures Dark & Lovely and Optimum — among the most widely used chemical relaxers in the country. Hair relaxer lawsuits allege L'Oréal knew its products contained endocrine-disrupting chemicals and formaldehyde releasers and failed to warn consumers of the cancer risk.
Revlon & Other Manufacturers — Chemical Hazard Concealment
Revlon, Dabur/Namaste (makers of ORS and Namaste products), and Strength of Nature (Just for Me, Motions, African Pride) all face claims that they formulated products with known chemical hazards — including parabens, phthalates, bisphenol-A, and formaldehyde releasers — without adequately disclosing the associated health risks.
Ovarian & Endometrial Cancer Claims
In addition to uterine cancer, hair relaxer lawsuits have been filed for ovarian cancer and endometrial cancer — both hormonally driven cancers with documented links to the endocrine-disrupting chemicals found in chemical relaxer formulations. These claims are based on overlapping scientific evidence regarding the carcinogenic mechanisms involved.
Uterine Fibroids — Non-Cancer Claims
Uterine fibroid claims are being filed by women who did not develop cancer but developed uterine fibroids — benign but often debilitating tumors — following long-term hair relaxer use. Fibroids are disproportionately prevalent in Black women and have documented links to the endocrine disruptors present in chemical relaxer products.
Targeted Marketing to Black Women — Disparate Impact Theory
Hair relaxer lawsuits also allege that manufacturers specifically and disproportionately marketed these products to Black women and girls — using culturally targeted advertising while knowingly suppressing the chemical hazard information that would have affected purchasing decisions. This theory adds a consumer protection and deceptive marketing dimension to the claims.
Eligibility
Your History May
Support a Claim
The core questions in hair relaxer litigation are straightforward: how long and how often did you use the product, and what diagnosis followed? A connected attorney makes the determination at no cost.
You used chemical hair relaxers regularly for a year or more
Long-term, frequent use — particularly four or more applications per year — is the primary exposure metric in current hair relaxer litigation. This aligns with the NIH study's findings and is the use pattern most strongly associated with elevated uterine cancer risk.
You were diagnosed with uterine, ovarian, or endometrial cancer
These three diagnoses are the primary basis of active hair relaxer cancer claims. Uterine cancer is the most well-supported by current scientific literature. A connected attorney can assess whether your diagnosis and use history support a viable claim.
You required surgery, chemotherapy, or radiation for a qualifying diagnosis
The extent of medical treatment received — including hysterectomy, oophorectomy, chemotherapy, radiation, or ongoing hormone therapy — directly affects the potential value of a hair relaxer settlement claim.
You were diagnosed with uterine fibroids requiring treatment
Uterine fibroids resulting in myomectomy, hysterectomy, embolization, or other medical intervention following long-term hair relaxer use may support a non-cancer claim. A connected attorney can assess whether your fibroid history qualifies.
You used Dark & Lovely, Optimum, Just for Me, ORS, Motions, or similar brands
Products from major manufacturers including L'Oréal/Soft Sheen (Dark & Lovely, Optimum), Strength of Nature (Just for Me, Motions, African Pride), and Namaste/Dabur (ORS) are the primary named products in current hair relaxer litigation.
Your diagnosis occurred within the past several years
Statutes of limitation apply and vary by state — typically two to three years from diagnosis or from when the connection between the hair relaxer and the diagnosis was discovered. A connected attorney can assess your specific deadline at no cost.
How It Works
No Upfront Cost.
Every Step Handled.
Attorneys in this network manage every aspect of your hair relaxer lawsuit or settlement claim. You share your product and medical history — they handle the rest at zero cost to you.
Free Confidential Evaluation
A connected attorney reviews the brands you used, the duration and frequency of use, and your diagnosis. You'll know quickly whether your claim is viable — no commitment required, no cost.
Medical & Product Documentation
Medical records, purchase history, product use evidence, and expert witnesses are gathered to establish the causal connection between your hair relaxer exposure and your diagnosis.
Filing & MDL Coordination
Your claim is filed and coordinated with the federal MDL in Illinois. L'Oréal, Revlon, and other named defendants are served and litigation proceeds.
Settlement or Verdict
The attorney's fee comes only from your recovery. You never pay anything out of pocket at any stage — no exceptions.
From Those Who Filed
Their Words
"I used Dark & Lovely for over twenty years, starting as a teenager. My uterine cancer diagnosis came at 41. When the NIH study came out, everything clicked. I had no idea there was a legal path."
"My mother used Just for Me on my hair from age seven. I'm 36 and was diagnosed with uterine cancer last year. The free evaluation took less than 20 minutes and I had an attorney within 48 hours."
"I didn't have cancer — I had fibroids so severe I needed a hysterectomy at 38. A friend told me fibroids might qualify too. The attorney confirmed they did. I had no idea the relaxer was connected."
Common Questions
What You Need to Know
Yes. A federal MDL consolidating hair relaxer cancer lawsuits is active in the Northern District of Illinois against L'Oréal, Revlon, Namaste, and other manufacturers. New cases are still being accepted. Submit your information for a free evaluation to find out if your claim qualifies.
A 2022 NIH/NIEHS study of over 33,000 women found that frequent hair relaxer use was associated with more than double the risk of uterine cancer. This study is the scientific foundation of current hair relaxer litigation and is cited in every active case. A connected attorney can explain how this applies to your claim.
Yes. Dark & Lovely and Optimum — both made by L'Oréal's Soft Sheen Products subsidiary — are among the most commonly named products in current hair relaxer litigation. Tell us your product and medical history for a free evaluation.
Uterine cancer has the strongest scientific documentation, followed by ovarian cancer and endometrial cancer. Uterine fibroids have also been the basis of active claims. Chemical relaxers contain endocrine-disrupting chemicals including parabens, phthalates, and formaldehyde releasers with documented hormonal cancer links. A connected attorney can assess your specific diagnosis.
Settlement values depend on the severity of the diagnosis, duration and frequency of product use, and the extent of medical treatment required. Cases involving uterine cancer requiring surgery, chemotherapy, or radiation tend toward higher potential value. A connected attorney can give you a clearer picture in a free, confidential evaluation.
Yes — statutes of limitation vary by state, typically two to three years from diagnosis or discovery of the hair relaxer connection. With the MDL advancing, filing now is strongly advised. Contact a connected attorney today to find out your deadline.
Yes. Many plaintiffs used multiple brands over many years and each manufacturer can be named. The longer the cumulative use history and the more brands involved, the stronger the exposure evidence. A connected attorney can assess which manufacturers apply to your history.
Your Diagnosis Isn't Coincidence.
Neither Is This Lawsuit.
The evaluation is free. The consultation is confidential. There is no obligation until you choose to move forward.